Results 11 to 20 of about 24,711 (245)
Severity of coeliac disease and clinical management study when using a CYP3A4 metabolised medication: a phase I pharmacokinetic study [PDF]
BMJ Open, 2020 Objective Severity of coeliac disease depends in part on the extent of small intestinal mucosa injury. Patients with the most abnormal pathology have loss of duodenal villi CYP3A4, a drug-metabolising enzyme that inactivates many drugs.
Marc L Chretien +6 more
doaj +2 more sources
Is mass screening for coeliac disease a wise use of resources? A health economic evaluation
BMC Gastroenterology, 2021 Background Living with undiagnosed symptomatic coeliac disease is connected with deteriorated health, and persons with coeliac disease often wait a long time for their diagnosis. A mass screening would lower the delay, but its cost-effectiveness is still
Fredrik Norström +8 more
doaj +1 more source
Coeliac disease: no difference in milk and dairy products consumption in comparison with controls
BMJ Nutrition, Prevention & Health, 2020 Background Nutritional deficiencies are common in patients with coeliac disease and they can cause osteopenia among other associated diseases. Reduced consumption of milk and dairy products may play a major role in determining low bone mass in patients ...
Carolina Ciacci +3 more
doaj +1 more source
European Medical Journal Gastroenterology, 2021 Intussusception as the initial presentation of coeliac disease has been rarely reported, with an incidence of 1% in all coeliac disease presentations.
Melissa Kyriakos Saad +5 more
doaj +1 more source
The global burden of childhood coeliac disease: a neglected component of diarrhoeal mortality? [PDF]
PLoS ONE, 2011 OBJECTIVES: Coeliac disease has emerged as an increasingly recognised public health problem over the last half-century, and is now coming to be seen as a global phenomenon, despite a profound lack of globally representative epidemiological data.
Peter Byass +2 more
doaj +1 more source
Population-Based Screening for Coeliac Disease in Lithuanian Children from 2009 to 2014
Medicina, 2023 Background and Objectives. Coeliac disease is an autoimmune disorder provoked by a dietary group of proteins called gluten in genetically predisposed individuals.
Vaidotas Urbonas +2 more
doaj +1 more source
Diagnostic Delay in Coeliac Disease: A Survey among Danish Patients
Canadian Journal of Gastroenterology and Hepatology, 2022 Background. Coeliac disease affects around 1% of the population, although many cases remain undiagnosed. Underdiagnosis and diagnostic delay in coeliac disease may cause health complications and be a burden for both the patient and society.
Line Lund Kårhus +3 more
doaj +1 more source
Celiac disease in the COVID-19 pandemic
Journal of Translational Autoimmunity, 2021 Background: The COVID-19 pandemic has had an impact on global health. Design: The impact of the COVID-19 pandemic on patients with coeliac disease was assessed in the present review.
Gabriel Samasca, Aaron Lerner
doaj +1 more source
Mosaic deletion patterns of the human antibody heavy chain gene locus shown by Bayesian haplotyping
Nature Communications, 2019 High-throughput sequencing and analyzes of antibody repertoire provide important information on immune responses, but current methodologies are limited in sequence assembly precision and haplotype inference validity.
Moriah Gidoni +12 more
doaj +1 more source
BMJ Open, 2023 Objective The non-metabolised antihistamine fexofenadine has oral absorption resulting from transporter activity. Uptake by enterocyte organic anion transporting polypeptides and efflux by an ATP-binding cassette transporter (P-glycoprotein) are primary ...
Marc L Chretien +6 more
doaj +1 more source